« Drain business to BioNationOver 40.000 lifescience jobs available! »

Pricing and Reimbursement in the Pharma industry

09/29/08 | by The Lifescience-online Team [mail] | Categories: Site Content, General Information

Don't miss the last published article about Pricing and Reimbursement challenges.

Lifescience-online in order to provide you with relevant comments on trendy topics related to the pharmaceutical industry asks world-class experts to give a comprehensive and pertinent overview of the sectors in which they are working.

Mark Connolly, Managing Director of Global Market Access Solutions (GMAS), is a specialist in pricing strategies, reimbursement needs and development of market access. Its article "Pricing and Reimbursement challenges for new Pharmaceuticals and Medical Devices" will bring you a deep analysis of the dynamic environment of pricing and reimbursement. Within the pharmaceutical industry, setting the appropriate price for a product is a crucial and perilous process. Misevaluation can have devastating effects on product success and viability. Adaptation to this changing environment is a major challenge for the pharmaceutical and medical devices companies.
To have more information you can now meet the author on Bionation.

Looking forward to reading your comments!

Feedback awaiting moderation

This post has 9 feedbacks awaiting moderation...

Leave a comment


Your email address will not be revealed on this site.

Your URL will be displayed.
(Line breaks become <br />)
(Name, email & website)
(Allow users to contact you through a message form (your email will not be revealed.)